Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Federal Medicaid Cuts
  • Generic Drugs
  • High-Deductible Plans
  • Gun Violence Trauma
  • Hospital Nutrition

WHAT'S NEW

  • Federal Medicaid Cuts
  • Generic Drugs
  • High-Deductible Plans
  • Gun Violence Trauma
  • Hospital Nutrition

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Thursday, Jun 13 2019

Full Issue

Pelosi Addresses Some Of The Rumblings Of Discontent From Progressives Over Leadership's Drug Pricing Plan

The progressive wing of Democratic House lawmakers is angry over the way leadership has been crafting its drug pricing strategy. On Wednesday night, House Speaker Nancy Pelosi said she would take one of their key criticisms and adjust the number of drugs that Medicare could negotiate over. Meanwhile, the progressives called for six drugmakers to testify over price increases next week.

The Hill: Pelosi To Change Drug-Pricing Plan After Progressive Complaints

Speaker Nancy Pelosi (D-Calif.) is making changes to her drug pricing plan after complaints from the Congressional Progressive Caucus (CPC). Pelosi told lawmakers, including the heads of the Progressive Caucus, during a private meeting Wednesday night that she had heard their complaints. (Sullivan, 6/12)

Stat: House Progressives Invite Six Drug Makers Back To Capitol Hill

House progressives on Wednesday called for executives from six drug companies to appear on Capitol Hill next week to justify what the lawmakers termed unjustifiable price increases — the latest public display of displeasure from the Democratic Party’s left flank regarding House Speaker Nancy Pelosi’s approach to lowering pharmaceutical costs. (Facher, 6/12)

And in the upper chamber —

The Hill: Senate Judiciary Committee Plans Markup Of Drug Pricing Bill This Month

The Senate Judiciary Committee is planning a markup of legislation to lower drug prices this month, Sen. Lindsey Graham (R-S.C.), the panel’s chairman, told The Hill on Wednesday. The action from the Judiciary Committee is a sign of the movement on the issue of drug pricing in both parties, which could provide Congress with a rare bipartisan achievement this year. The Senate Finance Committee is also moving forward with drug pricing legislation this month or next. (Sullivan, 6/12)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Today, May 5
  • Monday, May 4
  • Friday, May 1
  • Thursday, April 30
  • Wednesday, April 29
  • Tuesday, April 28
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF